Related content

Treatment of the non neurogenic overactive bladder with botuline toxin a detrusorinjections

By Marchand W.   Merckx L.   Maes D.   Gillis J.   Everaert K.   De Ridder D.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 220-220

Elsevier

Access to resources Recommend Favorite

A comparison of extended-release oxybutynin and tolterodine for treatment of overactive bladder in women

By Sand Peter   Miklos John   Ritter Henry   Appell Rodney  

International Urogynecology Journal, Vol. 15, Iss. 4, 2004-08 ,pp. : 243-248

Springer Publishing Company

Access to resources Recommend Favorite

Botulinum-A Toxin Detrusor Injection as a Novel Approach in the Treatment of Bladder Spasticity in Children with Neurogenic Bladder

By Schulte-Baukloh H.   Michael T.   Sturzebecher B.   Knispel H.H.  

European Urology, Vol. 44, Iss. 1, 2003-07 ,pp. : 139-143

Elsevier

Access to resources Recommend Favorite

Impact of overactive bladder and lower urinary tract symptoms on sexual health in Japanese women

By Sako Tomoko   Inoue Miyabi   Watanabe Toyohiko   Ishii Ayano   Yokoyama Teruhiko   Kumon Hiromi  

International Urogynecology Journal, Vol. 22, Iss. 2, 2011-02 ,pp. : 165-169

Springer Publishing Company

Access to resources Recommend Favorite

Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community-based survey

By Liberman J.N.   Hunt T.L.   Stewart W.F.   Wein A.   Zhou Z.   Herzog A.R.   Lipton R.B.   Diokno A.C.  

Urology, Vol. 57, Iss. 6, 2001-06 ,pp. : 1044-1050

Elsevier

Access to resources Recommend Favorite